Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,059
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 1,421–1,440 of 18,346 recalls

FDA Recall Ongoing Historical recordClass III

Gabapentin Capsules, USP 300 mg, Rx Only, Packaged in a) 500-count bottles, NDC 62756-138-05; b) 1000-count bottles, NDC 62756-138-04, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Halol-Baroda Highway, Halol-389 350, Gujarat, India.

by SUN PHARMACEUTICAL INDUSTRIES INC

Reason
Cross Contamination
Published
April 16, 2025
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.

by Zydus Pharmaceuticals (USA) Inc

Reason
Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Published
April 16, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

C.H. Guenther & Son LLC

Product
365 Whole Foods Market Small Bites Macaroni & Cheese. Net W…
Reason
Undeclared allergen (eggs) and pork
Published
April 16, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

The Truck Farm, LLC

Product
Desert Farms Jalapeno Mustard. Caution to refrigerate after…
Reason
The product is in violation for not having an approved filed process and for not having monitoring records.
Published
April 16, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

MTN OPS, LLC

Product
MTN OPS MULTI-V Men's Daily Multivitamin dietary supplement,…
Reason
Undeclared soy flour
Published
April 16, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01

by Glenmark Pharmaceuticals Inc., USA

Reason
CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx Only, 1,000 Capsules per bottle, Manufactured by: Towa Pharmaceutical Europe, S.L., Martorelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical, Inc., Berkley Heights, NJ 07922, NDC 51991-747-10.

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations: presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the recommended interim limit.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.

by Amerisource Health Services LLC

Reason
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13

by BIOCON PHARMA INC

Reason
Failed dissolution specifications: lower than specifications
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Tolterodine Tartrate Extended-Release Capsules, 2 mg, 30 Capsules (3 x 10) Unit Dose carton, Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6592-04.

by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Reason
Failed Dissolution Specifications: Out of specification results obtained during routine stability testing for dissolution.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

FRUSELVA USA

Product
Good & Gather baby Pea, Zucchini, Kale & Thyme Vegetable Pur…
Reason
elevated level of lead
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Seabear Company

Product
SeaBear Smokedhouse Alehouse Clam Chowder is packaged in ret…
Reason
Recall was initiated due to potential failure of the seal and potential to be contaminated with Clostridium botulinum.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Seabear Company

Product
SeaBear Smokedhouse Salmon Chowder is packaged in flexible r…
Reason
Recall was initiated due to potential failure of the seal and potential to be contaminated with Clostridium botulinum.
Published
April 9, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4

by Exela Pharma Sciences LLC

Reason
Lack of Assurance of Sterility
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 kettle style Neti Pot, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00102 7

by Ascent Consumer Products Inc.

Reason
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

SinuCleanse Premixed SALINE PACKETS (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg) for Nasal Wash System, 60-count All Natural USP Grade Saline Packets, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00103 4

by Ascent Consumer Products Inc.

Reason
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass I

SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg), 30-count All Natural USP Grade Saline Packets and 1 Soft tip Squeeze Bottle, Net WT 0.1OZ (3g) each, Distributed by Ascent Consumer Products Inc., Melville, NY 11747, UPC 6 46011 00104 1

by Ascent Consumer Products Inc.

Reason
Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

babyganics, Sheer Blend, SPF 50 Mineral Sunscreen Fragrance Free (zinc oxide 20%), a) 1.7 FL OZ (50 mL) bottle, UPC 810035921658, b) 8 FL OZ (236 mL) bottle, UPC 810035921382, Dist. by KAS Direct, LLC, 1525 Howe St., Racine, WI 53403, Made in Canada.

by Johnson, S C and Son, Inc

Reason
Failed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed.
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.2% ROPivacaine HCl 200 mg/100 mL (2 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1259-75

by QuVa Pharma, Inc.

Reason
Lack of Assurance of Sterility
Published
April 2, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

fentaNYL Citrate PF 200 mcg/100 mL (2 mcg/ml) /0.125% Bupivacaine HCl 125 mg/100 mL (1.25 mg/mL), 100 ml in NS Yellow CADD FSFF, Injection for Epidural Use (Not intended For IV Use), Compounded, For Institutional or Office Use Only, QuVa Pharma, 1075 West Park One Drive, Suite 100, Sugar Land, Tx 77478. NDC: 70092-1255-75

by QuVa Pharma, Inc.

Reason
Lack of Assurance of Sterility
Published
April 2, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.